TotalMarketCap

Fortress Biotech

FBIONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$61.366 M

$1.84 -6.60%

Close of 6 Nov 2026

As of 6 Nov 2026, Fortress Biotech (FBIO) has a market capitalization of $61.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$63.3M

#2639 by revenue

Earnings

$37.0M

#1670 by earnings

Shares outstanding

33,311,012

Latest filing cover page

P/E ratio

1.7

Cap ÷ net income

Other share classes

Fortress Biotech lists more than one class of stock. Company figures above cover all classes combined.

FBIOP

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #314MAIA BiotechnologyMAIA$63.9M
  2. #315CingulateCING$61.4M
  3. #316Fortress BiotechFBIO$61.4M
  4. #317Tenax TherapeuticsTENX$61.2M
  5. #318Quantum CyberQUCY$60.6M

What if Fortress Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$846,657.67

Per share 460,140× higher

Bitcoin $1.53T

$45,811.17

Per share 24,897× higher

Apple $5.02T

$150,393.80

Per share 81,736× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Fortress Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.